BIOREGENX, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2021 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Bioregenx, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2021 to 2024.
  • Bioregenx, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $283K, a 71.5% increase year-over-year.
  • Bioregenx, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $442K, a 63.3% decline from 2023.
  • Bioregenx, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1.2M, a 2840% increase from 2022.
  • Bioregenx, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $41K, a 18.1% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $442K -$762K -63.3% Jan 1, 2024 Dec 31, 2024 10-K/A 2025-04-16
2023 $1.2M +$1.16M +2840% Jan 1, 2023 Dec 31, 2023 10-K/A 2025-04-16
2022 $41K -$9.03K -18.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-12
2021 $50K Jan 1, 2021 Dec 31, 2021 10-K 2023-04-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.